Table 4A.
Mutation | No. V600E tumors with mutations | No. V600K tumors with mutations | No. V600E tumors without mutation | No. V600K tumors without mutation | p-value |
---|---|---|---|---|---|
| |||||
ARID2_mut | 13 | 4 | 111 | 13 | 0.13 |
CDK4_mut | 2 | 0 | 122 | 17 | 1.00 |
CDKN2A_mut | 3 | 0 | 121 | 17 | 1.00 |
DDX3X_mut | 18 | 1 | 106 | 16 | 0.47 |
GNA11_mut | 4 | 3 | 120 | 14 | 0.04 |
GNAQ_mut | 0 | 0 | 124 | 17 | 1.00 |
IDH1_mut | 3 | 1 | 121 | 16 | 0.41 |
KIT_mut | 3 | 3 | 121 | 14 | 0.02 |
KRAS_mut | 0 | 0 | 124 | 17 | 1.00 |
MAP2K1_mut | 0 | 0 | 124 | 17 | 1.00 |
NF1_mut | 0 | 0 | 124 | 17 | 1.00 |
NRAS_mut | 0 | 0 | 124 | 17 | 1.00 |
PPP6C_mut | 7 | 1 | 117 | 16 | 1.00 |
PTEN_mut | 5 | 4 | 119 | 13 | 0.01 |
RAC1_mut | 16 | 2 | 108 | 15 | 1.00 |
RB1_mut | 4 | 0 | 120 | 17 | 1.00 |
TERT_MUT | 12 | 3 | 112 | 14 | 0.39 |
TP53_mut | 3 | 0 | 121 | 17 | 1.00 |
Data taken from the Supplementary Table 1 of TCGA publication [2]. p-value was computed using a two-side Fisher exact test.